BioSpace News Archive

Regardless of if your motivation is to increase your salary or find a job that is more interesting to you, preparing for a career change can take a lot of time and energy.

The newly-launched index takes a focused look at the breadth and depth of novel agents currently being developed within the most innovative pharmaceutical pipelines.

New features include upgraded refreshments and entertainment options, improved compensation, increased donor educational materials, and an expanded company website

One of the things the company reported that has raised eyebrows is that the drug statistically improved cognitive function in the patients as early as week 4. This would be a very quick patient response—and for that matter, given that many Alzheimer’s studies run for years, a 36-week study is at least half the length of a typical Alzheimer’s trial.

The eight new drugs listed below probably won’t make any television commercials, but they will make a world of difference to those who suffer from these rare diseases and disorders.

Preclinical results support the therapeutic potential of KB-1801 for the prevention of Cardiac Surgery-Associated Acute Kidney Injury and advancement into clinical development

A*STAR’s Institute of Bioengineering and Nanotechnology has teamed up with the Singapore Institute of Advanced Medicine Holdings Pte Ltd to explore how to better tackle nasopharyngeal carcinoma, a type of head and neck cancer, through targeted proton therapy.

The Annual General Meeting of BioArctic AB on May 9, 2019, adopted instructions regarding the appointment of the Nomination Committee.

MC Services AG, a leading international public relations and investor relations firm, announced that it will support the 25th annual BIO-Europe® 2019, Europe’s largest partnering conference for the global life sciences industry, as a media partner.

Leveraging the concept of virtual assistants, BASF expertise becomes available to its customers, supporting during all stages of the drug development process